Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

Hjalmar Flygt; Stina Söderlund; Johan Richter; Susanne Saussele; Perttu Koskenvesa; Leif Stenke; Satu Mustjoki; Andreja Dimitrijevic; Jesper Stentoft; Waleed Majeed; Lydia Roy; Dominik Wolf; Arta Dreimane; Bjørn Tore Gjertsen; Tobias Gedde-Dahl; Erik Ahlstrand; Berit Markevärn; Henrik Hjorth-Hansen; Jeroen Janssen; Ulla Olsson-Strömberg

doi:10.1038/s41375-024-02184-z

. 2024 Feb 28;38(4):925. doi: 10.1038/s41375-024-02184-z

Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

Hjalmar Flygt ^1,^✉, Stina Söderlund ¹, Johan Richter ², Susanne Saussele ³, Perttu Koskenvesa ⁴, Leif Stenke ⁵, Satu Mustjoki ^4,^6,⁷, Andreja Dimitrijevic ⁸, Jesper Stentoft ⁹, Waleed Majeed ¹⁰, Lydia Roy ¹¹, Dominik Wolf ^12,¹³, Arta Dreimane ¹⁴, Bjørn Tore Gjertsen ¹⁵, Tobias Gedde-Dahl ¹⁶, Erik Ahlstrand ¹⁷, Berit Markevärn ¹⁸, Henrik Hjorth-Hansen ¹⁹, Jeroen Janssen ^20,^#, Ulla Olsson-Strömberg ^1,^#

¹Department of Medical Science and Division of Hematology, Uppsala University Hospital, Uppsala, Sweden

²Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden

³Medical Clinic, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany

⁴Department of Hematology, Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

⁵Department of Hematology, Karolinska University Hospital and Department of Medicine, Karolinska Institutet, Stockholm, Sweden

⁶Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland

⁷ICAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland

⁸Department of Hematology, Odense University Hospital, Odense, Denmark

⁹Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

¹⁰Department of Hemato-Oncology, Stavanger University Hospital, Stavanger, Norway

¹¹French CML group Fi-LMC, Centre Léon Bérard, Lyon, Hôpital Universitaire Henri Mondor, AP-HP, Service d’hématologie Clinique & Faculté de Santé, Université Paris Est Créteil, Créteil, France

¹²Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Tyrolean Cancer Research Institute (TKFI), Medical University Innsbruck, Innsbruck, Austria

¹³Medical Clinic 3, Universitätsklinikum, Bonn, Germany

¹⁴Department of Hematology, Linköping University Hospital, Linköping, Sweden

¹⁵Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway

¹⁶Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

¹⁷Department of Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

¹⁸Department of Hematology, Umeå University Hospital, Umeå, Sweden

¹⁹Department of Hematology, St. Olavs Hospital, Trondheim, Norway

²⁰Department of Hematology, Radboud University medical center, Nijmegen, The Netherlands

^✉

Corresponding author.

^#

Contributed equally.

PMCID: PMC10997495 PMID: 38418611

Correction to: Leukemia 10.1038/s41375-024-02145-6 published online 26 January 2024

The information provided in the Figure III legend states:

“TFR probability at 6, 12 and 24 months was 62, 55 and 42%respectively”, the figure should have appeared as shown below:

“TFR probability at 6, 12 and 24 months was 61, 56 and 46%, respectively”

PERMALINK

Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

Hjalmar Flygt

Stina Söderlund

Johan Richter

Susanne Saussele

Perttu Koskenvesa

Leif Stenke

Satu Mustjoki

Andreja Dimitrijevic

Jesper Stentoft

Waleed Majeed

Lydia Roy

Dominik Wolf

Arta Dreimane

Bjørn Tore Gjertsen

Tobias Gedde-Dahl

Erik Ahlstrand

Berit Markevärn

Henrik Hjorth-Hansen

Jeroen Janssen

Ulla Olsson-Strömberg

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

Hjalmar Flygt

Stina Söderlund

Johan Richter

Susanne Saussele

Perttu Koskenvesa

Leif Stenke

Satu Mustjoki

Andreja Dimitrijevic

Jesper Stentoft

Waleed Majeed

Lydia Roy

Dominik Wolf

Arta Dreimane

Bjørn Tore Gjertsen

Tobias Gedde-Dahl

Erik Ahlstrand

Berit Markevärn

Henrik Hjorth-Hansen

Jeroen Janssen

Ulla Olsson-Strömberg

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases